Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**The Klebsiella pneumoniae cell wall is a rigid, multilayered structure that surrounds the bacterial cell, composed primarily of a thin peptidoglycan layer and an outer membrane rich in lipopolysaccharide and other polysaccharides.** It plays essential roles in maintaining structural integrity, preventing osmotic lysis, and protecting the bacterium from host immune responses. The peptidoglycan consists of alternating units of N-acetyl-glucosamine and N-acetyl-muramic acid crosslinked by short peptides, while associated enzymes (like D-Ala-D-Ala carboxypeptidases) are critical in its biosynthesis and remodeling[1][4]. The cell wall is a principal target of many antibiotics—particularly beta-lactams and carbapenems—which inhibit peptidoglycan synthesis, leading to bacterial death[2][4]. Disruption of the cell wall (e.g., by molecular nanomachines or lytic enzymes) markedly increases the susceptibility of multidrug-resistant K. pneumoniae to antibiotics[2]. Cell wall architecture and associated mechanisms underlie K. pneumoniae’s notable multidrug resistance, as the outer membrane acts as a permeability barrier and is central to both the pathogen’s virulence and challenges in clinical therapy[5][4].
Inhibition of peptidoglycan biosynthesis (beta-lactams, carbapenems); Disruption/increase of cell wall permeability (by molecular nanomachines); Enzyme inhibition (e.g., D-Ala-D-Ala peptidases)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Klebsiella pneumoniae cell wall (null).